Biological collection
ApprovedBiologic
Biological collection is one of 228 biologic programs targeting Cachexia. It is currently in Approved.
8
Indications
13
Total Trials
7
Active Trials
227
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
1931 competitors in COVID-19
#DrugCompanyPhaseTrials
1Biological collection
AAssistance Publique - Hôpitaux de Paris
Approved
Spikevax
ModernaPreclinical
Stivarga
BayerPreclinical
Calciferol
Alnylam PharmaceuticalsPreclinical
Tricor
JJagotec
Preclinical
Achromycin V
WWyeth-Lederle Vaccines
Preclinical
Statin
Bristol-Myers SquibbPreclinical
Calcium
Eli LillyPreclinical
Selenium
SSWOG Cancer Research Network
Preclinical
Conventional
PPopulation Health Research Institute
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Brain Injury1 trial
8 more indications
CAR1 trial
Imaging1 trial
Liquid Biopsies and IMAging for Improved Cancer Care
Active, not recruiting·IInstitut du Cancer de Montpellier - Val d'Aurelle·N/A·NCT04224779·16 enrolled
Stroke1 trial
Clinical and Biological Strokes Collection in Reunion Island
Completed·—·N/A·NCT05598138·795 enrolled
Chronic pain1 trial
Unspecified1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Biological collection. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details